In contrast to previous data [14, 15], high LDB1 expression in the primary tumor was significantly associated with decreased overall survival (66.2 vs. 31.5 months, Hazard Ratio (HR) = 5.86, p = 0.003) (Figure 1A) in our cohort of CRC patients. The gene discussed is LDB1; the disease is colorectal carcinoma.